Not exact matches
Denmeade says the combination of drugs that block testosterone production and
receptors, called
androgen deprivation therapy, may
make prostate cancer more aggressive over time by enabling prostate cancer cells to subvert attempts to block testosterone
receptors.
The cells also might react by
making fewer
receptors, which may
make the prostate tumor cells vulnerable once more to
androgen deprivation therapy.
Androgen receptor distribution in the social decision -
making network of eusocial naked mole - rats.